Manish Arora, BDS, MPH, PhD
Manish Arora is the founder and CEO of Linus Biotechnology — a precision medicine clinical stage company. His co-founders are Drs. Christine Austin PhD and Paul Curtin PhD. Dr. Arora, an environmental epidemiologist and exposure biologist, is also the Edith J.Baerwald Professor and Vice Chairman of the Department of Environmental Medicine and Public Health at the Icahn School of Medicine at Mount Sinai.
Dr. Arora’s research focuses on the effects of prenatal and early life chemical exposures on life- long health trajectories. In 2020, he and colleagues proposed the “Biodynamic Interface Theory,” a novel theoretical framework that explains how the environment interacts with physiology in a dynamic way over time. This theory has the potential to shift the paradigm of environmental health research from a static to a more nuanced dynamic view of health throughout the life course. In Dr. Arora’s own research, environmental dynamic principles paved the way for his groundbreaking work on the tooth and hair biomarkers. Drs. Arora, Curtin and Austin led this technology to an FDA Breakthrough Designation for an autism biomarker that can be applied at birth.
Dr. Arora is currently the Principal Investigator or Co Investigator of eight research projects funded by the National Institute of Environmental Health Sciences (NIEHS), including the Human Health Exposure Analysis Resource (HHEAR) Untargeted Center grant, and the R35/RIVER grant. He has received multiple honors throughout his career, including the Presidential Early Career Award for Scientists and Engineers (PECASE) awarded by President Barack Obama in 2015 and the National Institutes of Health Director’s New Innovator Award in 2014.
Dr. Arora is the author of the book Environmental Biodynamics: A New Science of How the Environment Interacts with Human Health, published by Oxford University Press in December 2021.
